Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease. - sprookjes - yvandenbroek - TriplyDB

Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease.

Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease.

http://www.wikidata.org/entity/Q31117183

about

Progressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature.Prompt remission of severe SLE with only three doses of rituximab infusion and low dose steroid: the first case report from Indonesia.Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression American Society of Nephrology quiz and questionnaire 2013: glomerulonephritis.Emerging viral infections of the central nervous system: part 2 Rapidly progressive cerebellar ataxia in West Wales Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective.Incidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseases Efficacy and safety of rituximab therapy for systemic lupus erythematosus: a systematic review and meta-analysis Rituximab therapy for juvenile-onset systemic lupus erythematosus.Progressive Multifocal Leukoencephalopathy and Systemic Lupus Erythematosus: Focus on Etiology.Perspectives of public health laboratories in emerging infectious diseases.Treating multiple sclerosis with monoclonal antibodies.The Janus of lupus--benefits and risks with B-cell therapy.Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.Inflammatory infratentorial progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis.Why can't we find a new treatment for SLE?Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases.Clinically validated approaches to the treatment of autoimmune diseases.Progressive multifocal leukoencephalopathy and promyelocytic leukemia nuclear bodies: a review of clinical, neuropathological, and virological aspects of JC virus-induced demyelinating disease Clinical evaluation of natalizumab for formulary consideration.Progressive multifocal leukoencephalopathy and natalizumab.Neurologic complications in patients with inflammatory bowel disease: increasing relevance in the era of biologics.B-cell depletion in the treatment of lupus nephritis.Rituximab: emerging treatment strategies of immune-mediated glomerular disease.Novel immunomodulatory approaches for the management of multiple sclerosis.Neurology of rheumatologic disorders.The role of integrin antagonists in the treatment of inflammatory bowel disease.Sorting out the risks in progressive multifocal leukoencephalopathy.A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy.Safety issues and concerns of new immunomodulators in rheumatology.Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus: a systematic literature review.Update on the use of rituximab for intractable rheumatoid arthritis.Efficacy and safety of rituximab in pediatric neuromyelitis optica.Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression.JC polyomavirus reactivation is common following allogeneic stem cell transplantation and its preemptive detection may prevent lethal complications.Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy Immunosuppressive therapy in dermatology and PML.

P2860

Q30235523-380336DB-DDE5-4078-8DD3-9A15EFFFF57C Q31145483-5E49FAC9-A674-4B16-9F34-D43E144876C2 Q33382447-8FF2C038-1FDC-42AC-AB30-E9F35E8CF56E Q33510514-3DE9D73C-0F3B-4C49-B231-622B923B6F19 Q33571864-B592825C-6017-4A52-A0B0-34A66DCC724E Q33877744-B4C04B4D-4B7D-40D2-9373-D7E175B295B6 Q35050193-395F15D8-EBF2-41E8-9CD8-C0F3D709E8EC Q35237588-9521C5B5-F365-449C-B3B3-BC5611087FF2 Q35846542-CDC9298D-7548-4D6E-AD86-AA101A34A157 Q36219954-4EE786CC-CF31-47E6-BFAB-0B2A3FE4C65C Q36407310-3EB08969-8C98-4E4A-A73B-E38A575F8470 Q36766244-0B4F48F2-5FB1-43D3-B35B-AF25FBD9AAD7 Q36969626-13BA9624-7F1B-4794-B296-E61B7611E4ED Q37111904-A8DB4141-2FA8-402D-ABB7-39F53191CBD2 Q37168037-B51807F8-754F-4630-A673-2F7089835211 Q37196796-F0D73426-9B7C-427C-8C8A-91171C5BD6A5 Q37198798-C02528A2-B051-491D-80E4-3546953505EA Q37236049-EECA07EF-D017-413C-8FF8-9493951D9B43 Q37361949-AFAB587B-3506-4AF3-BB0D-D9D490C806D6 Q37541561-3EFD3F0E-DAF7-4C98-85A5-3D2AA2748B24 Q37668612-1DFC099B-84D8-4B80-8FC2-94E5C1123F77 Q37750534-8C16D4C4-C9C1-4B19-926E-09655E321413 Q37772171-4CC0F558-79A7-444C-A0AE-2C9B6F2B7C5D Q37885823-732005BA-FE83-4731-BB59-01A7F2E73E5C Q38007126-8065BDD9-B473-44B4-841B-87CF144376B6 Q38026784-D251FE15-17F4-4114-A42F-0451A52FA297 Q38033648-E36A7A6F-D3F2-431B-BC85-7173C39D3374 Q38156608-751CC144-3321-4D42-AE9B-CA6703C61CA6 Q38215698-46F78F07-5721-4A74-998E-6BEB4767FE07 Q38257410-43A42660-AABB-4970-89FA-98898276C233 Q38260098-EA0DF801-C6D4-4590-BF75-515D3D89E181 Q38268951-630F4EDF-1014-4740-88F5-D7AFD782E96B Q38292111-C6AF335C-0D92-4002-B1EF-852982F2F737 Q38689838-25C65370-BC02-4883-AE83-97581F22C463 Q38993240-F20A46C2-1513-49F6-9BB5-C7AEDD0AB801 Q39801735-46C60A5A-DCB9-4F8D-BFD9-3CAC81F1FD49 Q40641629-968A6C88-2992-45E3-8DC7-1CBD0F32D6F4 Q41339678-2198493B-489E-42D5-8F4D-F6D457EBC8EE Q42028548-DF621EDA-4AFE-4EAC-97C3-B949D328CCA9 Q43106475-1A43DE21-C649-4C08-8484-3A90784E0A2E

P2860

Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease.

http://www.wikidata.org/entity/Q31117183

description

2007 nî lūn-bûn

@nan

2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Progressive multifocal leukoen ...... athologic patterns of disease.

@ast

Progressive multifocal leukoen ...... athologic patterns of disease.

@en

type

label

Progressive multifocal leukoen ...... athologic patterns of disease.

@ast

Progressive multifocal leukoen ...... athologic patterns of disease.

@en

prefLabel

Progressive multifocal leukoen ...... athologic patterns of disease.

@ast

Progressive multifocal leukoen ...... athologic patterns of disease.

@en

P1433

Q31117183-FB7CA6C1-9E07-4C3C-8E8F-94AF47D3CBDE

P1476

Q31117183-8A7DA151-AD60-458F-B488-D26F4DAF41BC

P2093

Q31117183-114FB956-38CB-40BE-A37C-4FB2DADF8F2F

Q31117183-558B0925-DF51-4226-B335-AEC11D09787C

Q31117183-96D8B174-C02D-4B24-B938-3B6E792A4409

Q31117183-A4F56034-606B-477E-B84B-B2EFC55846B8

P2860

Q31117183-06FC502F-989B-40BB-B0A5-EBEAF7991015

Q31117183-42F0EAAF-493F-4195-9167-09C2B2A48CF5

Q31117183-5BA3AF60-FDDF-4A1A-85E9-309629E4F1DC

Q31117183-65AC230E-C034-4627-8FFE-358DCC13A64F

Q31117183-962862BD-CC50-4ACE-8685-6CE5F1F3F210

Q31117183-A3A20878-89C9-4894-8016-D1A49729CB21

Q31117183-DA479B56-E5CF-4D98-BF4F-A22C7AF26328

Q31117183-EBC1052C-1183-4963-B9DC-6AA174B0F35D

P304

Q31117183-195F4E3B-2AD5-42DB-98F6-1A8CD6AEEF56

P31

Q31117183-E1B52B5B-BA11-4333-AFA6-90AA0F98E1CD

P356

Q31117183-07E78F5D-5CC1-469C-A039-9506C9F6EEDD

P433

Q31117183-E2928CC2-C13A-412F-B3EA-791F38A1D0B6

P478

Q31117183-C2868FD3-9D1E-463E-92FE-A2D2905AC811

P577

Q31117183-5FFD5FBA-6094-46AB-A536-B56EC7018690

P5875

Q31117183-5937E22B-2626-45F4-95CD-7BA7CE836C89

P698

Q31117183-86C4DF79-0B74-4ACA-9D66-7BF2CDBCCAC9

P921

Q31117183-206475B7-E655-4857-94B8-33EF3E16543D

P356

P1433

Arthritis & Rheumatology

P1476

Progressive multifocal leukoen ...... athologic patterns of disease.

@en

P2093

DeRen Huang

http://www.w3.org/2001/XMLSchema#string

Eamonn S Molloy

http://www.w3.org/2001/XMLSchema#string

Leonard H Calabrese

http://www.w3.org/2001/XMLSchema#string

Richard M Ransohoff

http://www.w3.org/2001/XMLSchema#string

P2860

The changing pattern of HIV neuropathology in the HAART era.

Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy.

Cerebral vasculitis: MR imaging and angiographic correlation.

Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity?

The uninvited guest: JC virus infection of neurons in PML.

Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects.

Progressive multifocal leukoencephalopathy: unusual MRI findings and prolonged survival in a pregnant woman.

Progressive multifocal leukoencephalopathy: a complication of immunosuppressive treatment.

P304

2116-2128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.22657

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6237341

http://www.w3.org/2001/XMLSchema#string

P698

17599729

http://www.w3.org/2001/XMLSchema#string

P921

progressive multifocal leukoencephalopathy